ProMIS Neurosciences
PMN
25 hedge funds and large institutions have $78M invested in ProMIS Neurosciences in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
4,238% more capital invested
Capital invested by funds: $1.8M → $78M (+$76.2M)
800% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 2
178% more funds holding
Funds holding: 9 → 25 (+16)
56.21% more ownership
Funds ownership: 12.29% → 68.5% (+56%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$19.3M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$12.5M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.4M |
| 4 |
TECP
Trails Edge Capital Partners
Atlanta,
Georgia
|
+$8.31M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$4.77K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.24K |
| 3 |
DEM
Disciplined Equity Management
Neptune Beach,
Florida
|
-$441 |
| 4 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$298 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$136 |
PMN Hedge Fund Activity: Q1 2026 in Review
25 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q1 2026, worth a combined $78M — up 4,238% from $1.8M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new PMN positions and 2 closed out — a net gain of 16 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $19.3M. The largest seller was Federation des caisses Desjardins du Quebec, cutting an estimated $4.77K.
- 25 institutional investors held ProMIS Neurosciences (PMN) as of Q1 2026, up from 9 in Q4 2025.
- Funds reported $78M of ProMIS Neurosciences stock for Q1 2026, up 4,238% quarter-over-quarter.
- 18 funds opened new ProMIS Neurosciences positions in Q1 2026 and 2 closed out, a net change of +16 holders.
- The largest ProMIS Neurosciences buyer in Q1 2026 was Janus Henderson Group, an estimated $19.3M added.
- The largest ProMIS Neurosciences seller in Q1 2026 was Federation des caisses Desjardins du Quebec, an estimated $4.77K sold.
Based on aggregated 13F filings for Q1 2026.